158 related articles for article (PubMed ID: 24503208)
1. Multiple sclerosis in New Zealand.
Alla S; Mason DF
J Clin Neurosci; 2014 Aug; 21(8):1288-91. PubMed ID: 24503208
[TBL] [Abstract][Full Text] [Related]
2. The increasing prevalence of multiple sclerosis in New Zealand.
Alla S; Pearson J; Debernard L; Miller D; Mason D
Neuroepidemiology; 2014; 42(3):154-60. PubMed ID: 24556851
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis is more prevalent in northern New Zealand than previously reported.
Chancellor AM; Addidle M; Dawson K
Intern Med J; 2003 Mar; 33(3):79-83. PubMed ID: 12603579
[TBL] [Abstract][Full Text] [Related]
4. MS prevalence in New Zealand, an ethnically and latitudinally diverse country.
Taylor BV; Pearson JF; Clarke G; Mason DF; Abernethy DA; Willoughby E; Sabel C
Mult Scler; 2010 Dec; 16(12):1422-31. PubMed ID: 20813774
[TBL] [Abstract][Full Text] [Related]
5. The latitude gradient for multiple sclerosis prevalence is established in the early life course.
Sabel CE; Pearson JF; Mason DF; Willoughby E; Abernethy DA; Taylor BV
Brain; 2021 Aug; 144(7):2038-2046. PubMed ID: 33704407
[TBL] [Abstract][Full Text] [Related]
6. Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.
O'Connell K; Tubridy N; Hutchinson M; McGuigan C
Mult Scler Relat Disord; 2017 Apr; 13():75-80. PubMed ID: 28427707
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis in New Zealand Māori.
Pearson JF; Alla S; Clarke G; Taylor BV; Miller DH; Richardson A; Mason DF
Mult Scler; 2014 Dec; 20(14):1892-5. PubMed ID: 24852927
[TBL] [Abstract][Full Text] [Related]
8. Latitudinal prevalence gradient of multiple sclerosis in Latin America.
Risco J; Maldonado H; Luna L; Osada J; Ruiz P; Juarez A; Vizcarra D
Mult Scler; 2011 Sep; 17(9):1055-9. PubMed ID: 21551216
[TBL] [Abstract][Full Text] [Related]
9. Multiple Sclerosis impact on employment and income in New Zealand.
Pearson JF; Alla S; Clarke G; Mason DF; Anderson T; Richardson A; Miller DH; Sabel CE; Abernethy DA; Willoughby EW; Taylor BV
Acta Neurol Scand; 2017 Sep; 136(3):223-232. PubMed ID: 27891575
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.
McLeod JG; Hammond SR; Hallpike JF
Med J Aust; 1994 Feb; 160(3):117-22. PubMed ID: 8295576
[TBL] [Abstract][Full Text] [Related]
11. High prevalence and no latitude gradient of multiple sclerosis in Norway.
Berg-Hansen P; Moen SM; Harbo HF; Celius EG
Mult Scler; 2014 Nov; 20(13):1780-2. PubMed ID: 24603884
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis.
Hollingworth S; Walker K; Page A; Eadie M
Mult Scler; 2013 Nov; 19(13):1712-6. PubMed ID: 23530000
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis mortality in New Zealand: a nationwide prospective study.
Leadbetter R; MacAskill M; Myall DJ; Taylor BV; Joshi P; ; Mason DF
J Neurol Neurosurg Psychiatry; 2023 Jul; 94(7):511-517. PubMed ID: 36882223
[TBL] [Abstract][Full Text] [Related]
14. An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand.
Alla S; Pearson JF; Taylor BV; Roxburgh R; Clarke G; Miller DH; Richardson A; Abernethy DA; Willoughby E; Sabel CE; Mason DF
Mult Scler; 2016 Apr; 22(5):705-7. PubMed ID: 26432856
[No Abstract] [Full Text] [Related]
15. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?
Miller DH; Hammond SR; McLeod JG; Purdie G; Skegg DC
J Neurol Neurosurg Psychiatry; 1990 Oct; 53(10):903-5. PubMed ID: 2266373
[TBL] [Abstract][Full Text] [Related]
16. Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis.
Simpson S; Wang W; Otahal P; Blizzard L; van der Mei IAF; Taylor BV
J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1193-1200. PubMed ID: 31217172
[TBL] [Abstract][Full Text] [Related]
17. Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.
Taylor BV; Palmer A; Simpson S; Lucas R; ; Simmons RD; Mason D; Pearson J; Clarke G; Sabel C; Willoughby E; Richardson A; Abernethy D
Mult Scler; 2013 Oct; 19(12):1627-31. PubMed ID: 23530001
[TBL] [Abstract][Full Text] [Related]
18. High nationwide prevalence of multiple sclerosis in Sweden.
Ahlgren C; Odén A; Lycke J
Mult Scler; 2011 Aug; 17(8):901-8. PubMed ID: 21459810
[TBL] [Abstract][Full Text] [Related]
19. Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity.
McGuigan C; McCarthy A; Quigley C; Bannan L; Hawkins SA; Hutchinson M
J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):572-6. PubMed ID: 15026499
[TBL] [Abstract][Full Text] [Related]
20. The changing demographic pattern of multiple sclerosis epidemiology.
Koch-Henriksen N; Sørensen PS
Lancet Neurol; 2010 May; 9(5):520-32. PubMed ID: 20398859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
